There was also a trend towards higher granzyme B expression in the Eomes + Tbet++ Mtb-specific IFNγ+CD4 + subset in patients with TB-IRIS compared to non-IRIS controls at week 2 (median: 19.7% vs 2.9%, respectively; P = .063) (Figure 5B). This evidence concerns the gene GZMB and tuberculosis.